Mukherjee, Kumar
Gunsoy, Necdet B.
Kristy, Rita M.
Cappelleri, Joseph C.
Roydhouse, Jessica
Stephenson, Judith J.
Vanness, David J.
Ramachandran, Sujith
Onwudiwe, Nneka C.
Pentakota, Sri Ram
Karcher, Helene
Di Tanna, Gian Luca http://orcid.org/0000-0002-5470-3567
Funding for this research was provided by:
SUPSI - University of Applied Sciences and Arts of Southern Switzerland
Article History
Accepted: 15 June 2023
First Online: 25 July 2023
Declarations
:
: None of the authors received support for their participation and contribution in this article. All authors volunteered their time for the discussion, research, and writing of this article. None of the authors had any financial or non-financial interests that are directly or indirectly related to this article. However, the following authors disclose the following: Kumar Mukherjee has received two research grants during the previous 3 years from the Harvey L. Neiman Health Policy Institute and Emory University and Organic Remedies outside the submitted work. Necdet Gunsoy has received personal fees from GlaxoSmith Kline previously. He is an employee and shareholder of AbbVie, which has no financial or non-financial interests that are directly or indirectly related to this article. Rita Kristy is an employee of Astellas Pharma, which has no financial or non-financial interests that are directly or indirectly related to this article. Joseph C. Cappelleri is an employee and stockholder of Pfizer Inc, which has no financial or non-financial interests that are directly or indirectly related to this article. Jessica Roydhouse has received personal fees from Amgen and grants from Royal Hobart Hospital Research Foundation and U Birmingham Enterprise through her employer, outside the submitted work. Helene Karcher is an employee and shareholder of Novartis, which has no financial or non-financial interests that are directly or indirectly related to this article. She is also the Editor-in-Chief of the journal <i>Epidemiologic Methods</i>, from where she receives an annual honorarium outside of the submitted work. Gian Luca Di Tanna has received fees paid by Amgen and Gilead Sciences, Inc. to his previous employer for methodological support on many projects outside the submitted work.
: Not applicable.
: Not applicable.
: Not applicable.
: All data analyzed as part of this study are included in this published article (and its supplementary information files).
: Not applicable.
: KM: literature selection, reviewed the data, statistical analysis and interpretation of data, drafted the manuscript. NG: conceptualization and design, literature search and selection, quality assessment of included studies, data extraction, reviewed and revised the manuscript. RK: conceptualization and design, literature search and selection, reviewed the data, reviewed and revised the manuscript. JC: conceptualization and design, reviewed the data, reviewed and revised the manuscript. JR: reviewed the data generated, reviewed and revised the manuscript. JS: reviewed the data generated, reviewed and revised the manuscript. DV: conceptualization and design, reviewed the data, reviewed and revised the manuscript. SR: reviewed the data generated, reviewed and revised the manuscript. NO: reviewed the data generated, reviewed and revised the manuscript. SRP: reviewed the data generated, reviewed and revised the manuscript. HK: conceptualization and design, literature search and selection, quality assessment of included studies, data extraction, reviewed the data generated, reviewed and revised the manuscript. GLDT: conceptualization and design, literature selection, quality assessment of included studies, drafted the manuscript, supervision of the manuscript.